<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0034-7531</journal-id>
<journal-title><![CDATA[Revista Cubana de Pediatría]]></journal-title>
<abbrev-journal-title><![CDATA[Rev Cubana Pediatr]]></abbrev-journal-title>
<issn>0034-7531</issn>
<publisher>
<publisher-name><![CDATA[Centro Nacional de Información de Ciencias MédicasEditorial Ciencias Médicas]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0034-75312019000300015</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Avances en el conocimiento de la patogénesis del síndrome hemolítico urémico]]></article-title>
<article-title xml:lang="en"><![CDATA[Breakthrough in the knowledge on pathogenesis of haemolytic uremic syndrome]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Mena Miranda]]></surname>
<given-names><![CDATA[Vivian Rosario]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Puig Souza]]></surname>
<given-names><![CDATA[Leyris]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital Pediátrico Docente de Centro Habana  ]]></institution>
<addr-line><![CDATA[La Habana ]]></addr-line>
<country>Cuba</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>09</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>09</month>
<year>2019</year>
</pub-date>
<volume>91</volume>
<numero>3</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S0034-75312019000300015&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S0034-75312019000300015&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S0034-75312019000300015&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN El objetivo propuesto es reordenar los conocimientos sobre el síndrome hemolítico urémico en los pediatras, que se enfrentan al manejo de pacientes con esta enfermedad en los servicios de urgencia, hospitalización y unidades de cuidado intensivo. Actualmente se considera una enfermedad rara o emergente. El 90 % de los casos es causado, fundamentalmente, por una infección entérica con Escherichia coli productora de toxina Shiga. La infección en humanos está provocada por el consumo de carne contaminada poco cocida, leche no pasteurizada o productos lácteos, agua, fruta y vegetales. El período de incubación, después de la ingestión de estos productos, es de 1 a 10 días. El diagnóstico del síndrome se basa en la presencia de pródromo diarreico asociado a anemia hemolítica microangiopática, trombocitopenia y daño renal agudo, elementos que caracterizan la enfermedad. La trombocitopenia puede ser transitoria y no detectada en los exámenes de laboratorio. Un recuento de plaquetas &gt; 150 000 pudiera ser un marcador indirecto de resolución del proceso microangiopático. Clínicamente suele iniciarse con dolor abdominal, diarrea y desarrollo entre los 4-10 días de fracaso renal agudo. El tratamiento actual de los pacientes con el síndrome es de sostén, aunque se está usando el anticuerpo monoclonal recombinante Eculizumab, también, las terapias de recambio plasmático como tratamiento de primera línea tan pronto como se realice el diagnóstico. El síndrome urémico hemolítico es una de las causas principales de falla renal aguda en niños. Su diagnóstico y tratamiento precoz y oportuno son la clave para prevenir las complicaciones de esta entidad.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT The proposed objective is to reorder the knowledge on haemolytic uremic syndrome´s management in pediatricians that have to face the care of patients suffering this disease in emergency services, hospitalization and intensive care units. Nowadays, it is considered a rare or emerging disease. In 90 % of the cases, it is caused mainly by an enteric infection with Escherichia coli which produces Shiga toxine. The infection in humans is provoqued by consumption of raw contamined meat, non-pasteurized milk or dairy products, water, fruits or vegetables. Incubation period after ingestion is of 1 to 10 days. The syndrome&#8217;s diagnostic is based in the presence of diarrheic prodome associated to microangiopathic hemolytic anemia; thrombocytopenia and acute renal damage which are elements that characterize the disease. Thrombocytopenia can be transitory and not detected in laboratory tests. Platelets count&gt; 150 000 could be an indirect marker of resolution in the microagniopathic process. Clinically speaking, it normally starts with abdominal pain, diarrhea and evolution in 4 to 10 days of acute renal damage. The current treatment for patients witht the syndrome is supportive treatment although it is also used the recombinant monoclonal antibody called Eculizumab; and also plasma recharge therapies as a front line treatment as soon as the diagnostic has been made. Hemolytic uremic syndrome is one of the main causes of acute renal failure in children. Its diagnostic and early and timely treatment are the key to prevent complications of this entity.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[síndrome hemolítico urémico]]></kwd>
<kwd lng="es"><![CDATA[Eculizumab]]></kwd>
<kwd lng="en"><![CDATA[hemolytic uremic syndrome]]></kwd>
<kwd lng="en"><![CDATA[Eculizumab]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Loza Munarriz]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Síndrome Urémico-hemolítico Problemas aún no resueltos]]></article-title>
<source><![CDATA[Rev Med Hered]]></source>
<year>2015</year>
<volume>26</volume>
<page-range>69-70</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cheung]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Trachtman]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hemolytic uremic syndrome toxins, vessels, and inflammation]]></article-title>
<source><![CDATA[Front Med (Lausanne)]]></source>
<year>2014</year>
<volume>1</volume>
<page-range>42</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bello-Márquez]]></surname>
<given-names><![CDATA[DC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Síndrome hemolítico urémico. Curso continuo de actualización en pediatría CCAP]]></article-title>
<source><![CDATA[Sociedad colombina de pediatría]]></source>
<year>2016</year>
<volume>14</volume>
<numero>4</numero>
<issue>4</issue>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Giménez Llorta]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Camacho Díaza]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Vila Cotsa]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Vila Santandreua]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Jordán García]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Palomeque Ricob]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Síndrome hemolítico-urémico Revisión de 58 casos]]></article-title>
<source><![CDATA[An Pediatr]]></source>
<year>2008</year>
<volume>69</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>297-303</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zambrano]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Delucchi]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Cavagnaro]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Hevia]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Rosati]]></surname>
<given-names><![CDATA[MP]]></given-names>
</name>
<name>
<surname><![CDATA[Lagos]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Síndrome hemolítico urémico en Chile presentación clínica, evolución y factores pronósticos]]></article-title>
<source><![CDATA[Rev Med Chile]]></source>
<year>2008</year>
<volume>136</volume>
<page-range>1240-6</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Valeria Prado]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Cavagnaro]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hemolytic uremic syndrome associated to shigatoxin producing Escherichia coli in Chilean children: Clinical and epidemiological aspects]]></article-title>
<source><![CDATA[Rev Chilena Infectol]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="book">
<collab>Medline plus</collab>
<source><![CDATA[Enciclopedia médica. Síndrome urémico hemolítico]]></source>
<year>2019</year>
<publisher-loc><![CDATA[EE. UU. ]]></publisher-loc>
<publisher-name><![CDATA[Biblioteca Nacional de Medicina]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="book">
<collab>Agencia Chilena para la Inocuidad y Calidad Alimentaria</collab>
<source><![CDATA[Ficha de Peligros: No. 07/2017/Versión 01. STEC. ACHIPIA, Área Soporte al Análisis de Riesgo. 1. Escherichia coli productora de toxina Shiga (STEC)]]></source>
<year>2017</year>
<publisher-loc><![CDATA[Chile ]]></publisher-loc>
<publisher-name><![CDATA[ACHIPIA]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Balestracci]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Toledo]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Battaglia]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
<name>
<surname><![CDATA[Lillo]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[More Cao]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Alvarado]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Síndrome urémico hemolítico asociado a diarrea sin trombocitopenia]]></article-title>
<source><![CDATA[Nefrología]]></source>
<year>2017</year>
<volume>37</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>508-14</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Abrey Recalde]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
</person-group>
<source><![CDATA[Interacción entre la respuesta trombótica y la respuesta inflamatoria en el Síndrome Urémico Hemolítico (SUH)]]></source>
<year>2016</year>
<publisher-loc><![CDATA[Buenos Aires ]]></publisher-loc>
<publisher-name><![CDATA[Facultad de Ciencias Exactas y Naturales de la Universidad de Buenos Aires]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ardissino]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Dacco]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Testa]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Civitillo]]></surname>
<given-names><![CDATA[CF]]></given-names>
</name>
<name>
<surname><![CDATA[Tel]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Possenti]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hemoconcentrarion A major risk factor for neurological involvement in hemolytic uremic syndrome]]></article-title>
<source><![CDATA[Pediatr Nephrol]]></source>
<year>2015</year>
<volume>30</volume>
<page-range>345-28</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sepúlveda]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
<name>
<surname><![CDATA[Tagle]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Jara]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Síndrome Hemolítico Uremico Atipico]]></article-title>
<source><![CDATA[Rev Med Chile]]></source>
<year>2018</year>
<volume>146</volume>
<page-range>770-9</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Picard]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Burtey]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Bornet]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Curti]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Montana]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Vanelle]]></surname>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pathophysiology and treatment of typical and athypical hemoliticuremic síndrome]]></article-title>
<source><![CDATA[Pathol Biol (París)]]></source>
<year>2015</year>
<volume>63</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>136-43</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Campistol]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Arias]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ariceta Blasco]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Espinosa]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Espinosa]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Actualización en Síndrome Hemolítico Atípico. Diagnóstico y Tratamiento. Documento de consenso]]></article-title>
<source><![CDATA[Nefrologia]]></source>
<year>2015</year>
<volume>35</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>421-47</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martoni-Fabregas]]></surname>
</name>
<name>
<surname><![CDATA[Moraga-Llop]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Nieto-Rey]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Nadal]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Soler-Palacin]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Roqueta-Más]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Enfermedad neumococica invasiva y Sindrome Hemolitico Urémico]]></article-title>
<source><![CDATA[An Pediatr (Barc)]]></source>
<year>2008</year>
<volume>68</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>269-72</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Córdoba]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
<name>
<surname><![CDATA[Contreras]]></surname>
<given-names><![CDATA[KM]]></given-names>
</name>
<name>
<surname><![CDATA[Larrarte]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Espitaleta]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[González]]></surname>
<given-names><![CDATA[LE]]></given-names>
</name>
<name>
<surname><![CDATA[Ibarra]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Síndrome hemolítico urémico atípico, revisión de la literatura y documento de consenso]]></article-title>
<source><![CDATA[Rev Colomb Nefrol]]></source>
<year>2015</year>
<volume>2</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>19-40</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Riedl]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Fakhouri]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Le Quintrec]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Noone]]></surname>
<given-names><![CDATA[DG]]></given-names>
</name>
<name>
<surname><![CDATA[Jungraithmayr]]></surname>
<given-names><![CDATA[TC]]></given-names>
</name>
<name>
<surname><![CDATA[Fremeaux-Bacchi]]></surname>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Spectrum of complement-mediated thrombotic microangiopathies pathogenetic insights identifying novel treatment approaches]]></article-title>
<source><![CDATA[Thromb Hemost]]></source>
<year>2014</year>
<volume>40</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>444-64</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Monteverde]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Síndrome urémico hemolítico]]></article-title>
<source><![CDATA[Nefrol Diál Traspl]]></source>
<year>2014</year>
<volume>34</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>27-41</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Canpolat]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hemolytic uremic syndrome]]></article-title>
<source><![CDATA[Turk Pediatric Ars]]></source>
<year>2015</year>
<volume>50</volume>
<page-range>73-82</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lulli-Cantoni]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Miyahira]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Frecuencia de secuela renal pos evento agudo en síndrome urémico hemolítico]]></article-title>
<source><![CDATA[Rev Med Hered]]></source>
<year>2015</year>
<volume>26</volume>
<page-range>51</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Monteverde]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
</person-group>
<source><![CDATA[Manejo del Síndrome Urémico-Hemolítico]]></source>
<year>2014</year>
<publisher-loc><![CDATA[Buenos Aires. Argentina ]]></publisher-loc>
<publisher-name><![CDATA[Hospital de Pediatría SAMIC "Prof. Dr. Juan Pedro Garrahan"]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tagle]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Rivera]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Walbaum]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Sepulveda]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Síndrome hemolítico urémico atípico en el tratamiento con eculizumab Casos clínicos]]></article-title>
<source><![CDATA[Rev Med Chile]]></source>
<year>2018</year>
<volume>146</volume>
<page-range>254-9</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
